Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma

Published:2017-06-13 Issue:20 Volume:123 Page:3904-3915
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Lin Wei-Cheng¹,Ding Yi-Fang²,Hsu Han-Lin³⁴,Chang Jer-Hwa³⁴,Yuan Kevin Sheng-Po²,Wu Alexander T. H.⁵,Chow Jyh-Ming⁶,Chang Chia-Lun⁶,Chen Shee-Uan⁷,Wu Szu-Yuan⁸⁹^ORCID

Affiliation:

1. Division of Thoracic Surgery; Department of Surgery, Wan Fang Hospital, Taipei Medical University; Taipei Taiwan

2. Department of Otorhinolaryngology; Wan Fang Hospital, Taipei Medical University; Taipei Taiwan

3. Division of Pulmonary Medicine; Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University; Taipei Taiwan

4. School of Respiratory Therapy; College of Medicine, Taipei Medical University; Taipei Taiwan

5. PhD Program for Translational Medicine; Taipei Medical University; Taipei Taiwan

6. Department of Hemato-Oncology; Wan Fang Hospital, Taipei Medical University; Taipei Taiwan

7. Department of Obstetrics and Gynecology; National Taiwan University Hospital; Taipei Taiwan

8. Department of Radiation Oncology; Wan Fang Hospital, Taipei Medical University; Taipei Taiwan

9. Department of Internal Medicine; School of Medicine, College of Medicine, Taipei Medical University; Taipei Taiwan

Funder

Taipei Medical University

Wan Fang Hospital

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference71 articles.

1. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques;Yen;Cancer.,2017

2. Multicenter phase 2 study of cisplatin and 5-fluorouracil with concurrent radiation therapy as an organ preservation approach in patients with squamous cell carcinoma of the cervical esophagus;Zenda;Int J Radiat Oncol Biol Phys.,2016

3. Primary radiotherapy compared with primary surgery in cervical esophageal cancer;Cao;JAMA Otolaryngol Head Neck Surg.,2014

4. Preoperative chemoradiotherapy for esophageal or junctional cancer;Hagen;N Engl J Med.,2012

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Effectiveness of Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiotherapy for Patients With Inoperable Esophageal Squamous Cell Carcinoma Undergoing Curative-Intent Concurrent Chemoradiotherapy;Journal of Thoracic Oncology;2023-12

2. Correspondence: The Causality Between Statin Use and Reduced Mortality of Esophageal Cancer Remains Unproven;Journal of Thoracic Oncology;2023-11

3. Leveraging Transcriptomics Data to Refine Immunotherapy Response Prediction in NSCLC: STK11 Deficiency and Beyond;Journal of Thoracic Oncology;2023-11

4. Correspondence: Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma;Journal of Thoracic Oncology;2023-10

5. Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Nationwide Cohort Study;Journal of Thoracic Oncology;2023-08